Great news that your LVEF is at 60% and you've been cleared — that's a solid number! The injection your oncologist mentioned is likely Phesgo, which combines Herceptin (trastuzumab) and Perjeta (pertuzumab) into one convenient subcutaneous injection given under the skin.
Here's what's helpful to know about it:
- It's Show Full Answer
Great news that your LVEF is at 60% and you've been cleared — that's a solid number! The injection your oncologist mentioned is likely Phesgo, which combines Herceptin (trastuzumab) and Perjeta (pertuzumab) into one convenient subcutaneous injection given under the skin.
Here's what's helpful to know about it:
- It's quicker than a traditional IV infusion, meaning less time in the clinic
- It's typically given once every three weeks
- Both medications target HER2 in different ways, which can make treatment more effective
- It can be used before or after surgery Since Herceptin can affect heart function, regular heart monitoring will likely continue to be part of your care plan — which your cardiology team is clearly already on top of. 👍
The key questions worth asking your oncologist include:
- How often will heart monitoring continue during treatment?
- Where will the injections be given — clinic or at home?
- What side effects should be watched for?
This sounds like a well-considered plan, but always feel comfortable asking your oncologist to walk through all the details with you.
August 11
Join
Your Privacy Choices
